ncRNA name
hsa-miR-130a
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
SOX9
Downstream target
CTR1
Cancer name
Cervical Cancer
Cancer site
Cervix Uteri
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
Up
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-130a mimics promoted the chemoresistance of the cervical cancer cell to DDP .
Tissue resource
cervical cancer tissues
human cervical cancer cell lines HeLa
human cervical cancer cell lines CaSki
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
the Second Xiangya Hospital of Central South University
American Type Culture Collection
Country
China
USA
Continent
Asia
North American